This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology Open Access 07 August 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mack, G. Osiris seals billion-dollar deal with Genzyme for cell therapy. Nat Biotechnol 27, 106–107 (2009). https://doi.org/10.1038/nbt0209-106
Issue Date:
DOI: https://doi.org/10.1038/nbt0209-106
This article is cited by
-
Challenges in the translation and commercialization of cell therapies
BMC Biotechnology (2015)
-
Genzyme backs Osiris, despite Prochymal flop
Nature Biotechnology (2009)